The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.
Kim Gaspar
Advertisement
Kim Gaspar, PhD, is manager of quality assurance at Helix BioPharma.
Articles by Kim Gaspar
Advertisement
Latest Updated Articles
Stabilization of Interferon alpha-2b in a Topical CreamPublished: July 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
